Clinical Determination of the Severity of Metabolic Syndrome: Preheparin Lipoprotein Lipase Mass as a New Marker of Metabolic Syndrome

Current Medicinal Chemistry: Cardiovascular and Hematological Agents · Published 2005-09-28 · DOI 10.2174/156801605774322292

Authors being retrieved — see the publisher record. https://doi.org/10.2174/156801605774322292

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2005

Related articles